Conglomerates
Compare Stocks
2 / 10Stock Comparison
HON vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
HON vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Conglomerates | Industrial - Machinery |
| Market Cap | $137.39B | $83.18B |
| Revenue (TTM) | $36.76B | $18.32B |
| Net Income (TTM) | $4.10B | $2.44B |
| Gross Margin | 36.9% | 39.4% |
| Operating Margin | 14.9% | 19.4% |
| Forward P/E | 20.6x | 22.8x |
| Total Debt | $34.58B | $13.76B |
| Cash & Equiv. | $12.49B | $1.54B |
HON vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Honeywell Internati… (HON) | 100 | 148.7 | +48.7% |
| Emerson Electric Co. (EMR) | 100 | 242.4 | +142.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HON vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HON carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- Rev growth 7.8%, EPS growth -15.5%, 3Y rev CAGR 1.8%
- Lower volatility, beta 0.74, current ratio 1.32x
EMR is the clearest fit if your priority is long-term compounding and valuation efficiency.
- 215.5% 10Y total return vs HON's 134.6%
- PEG 5.04 vs HON's 11.22
- 13.3% margin vs HON's 11.2%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 7.8% revenue growth vs EMR's 3.0% | |
| Value | Lower P/E (20.6x vs 22.8x) | |
| Quality / Margins | 13.3% margin vs HON's 11.2% | |
| Stability / Safety | Beta 0.74 vs EMR's 1.52 | |
| Dividends | 2.1% yield, 15-year raise streak, vs EMR's 1.4% | |
| Momentum (1Y) | +39.9% vs HON's +5.5% | |
| Efficiency (ROA) | 5.8% ROA vs HON's 5.3%, ROIC 8.2% vs 12.6% |
HON vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HON vs EMR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 2.0x EMR's $18.3B. Profitability is closely matched — net margins range from 13.3% (EMR) to 11.2% (HON). On growth, EMR holds the edge at +2.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $36.8B | $18.3B |
| EBITDAEarnings before interest/tax | $6.5B | $4.7B |
| Net IncomeAfter-tax profit | $4.1B | $2.4B |
| Free Cash FlowCash after capex | $4.2B | $3.1B |
| Gross MarginGross profit ÷ Revenue | +36.9% | +39.4% |
| Operating MarginEBIT ÷ Revenue | +14.9% | +19.4% |
| Net MarginNet income ÷ Revenue | +11.2% | +13.3% |
| FCF MarginFCF ÷ Revenue | +11.4% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -6.9% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -41.9% | +28.2% |
Valuation Metrics
HON leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 29.5x trailing earnings, HON trades at a 20% valuation discount to EMR's 36.6x P/E. Adjusting for growth (PEG ratio), EMR offers better value at 8.11x vs HON's 16.04x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $137.4B | $83.2B |
| Enterprise ValueMkt cap + debt − cash | $159.5B | $95.4B |
| Trailing P/EPrice ÷ TTM EPS | 29.46x | 36.61x |
| Forward P/EPrice ÷ next-FY EPS est. | 20.60x | 22.77x |
| PEG RatioP/E ÷ EPS growth rate | 16.04x | 8.11x |
| EV / EBITDAEnterprise value multiple | 20.05x | 18.89x |
| Price / SalesMarket cap ÷ Revenue | 3.67x | 4.62x |
| Price / BookPrice ÷ Book value/share | 9.03x | 4.13x |
| Price / FCFMarket cap ÷ FCF | 25.48x | 31.19x |
Profitability & Efficiency
EMR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
HON delivers a 23.1% return on equity — every $100 of shareholder capital generates $23 in annual profit, vs $12 for EMR. EMR carries lower financial leverage with a 0.68x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs HON's 6/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +23.1% | +12.1% |
| ROA (TTM)Return on assets | +5.3% | +5.8% |
| ROICReturn on invested capital | +12.6% | +8.2% |
| ROCEReturn on capital employed | +12.6% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 |
| Debt / EquityFinancial leverage | 2.24x | 0.68x |
| Net DebtTotal debt minus cash | $22.1B | $12.2B |
| Cash & Equiv.Liquid assets | $12.5B | $1.5B |
| Total DebtShort + long-term debt | $34.6B | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | 3.92x | 6.61x |
Total Returns (Dividends Reinvested)
EMR leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EMR five years ago would be worth $16,900 today (with dividends reinvested), compared to $10,364 for HON. Over the past 12 months, EMR leads with a +39.9% total return vs HON's +5.5%. The 3-year compound annual growth rate (CAGR) favors EMR at 22.6% vs HON's 5.2% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +11.3% | +9.3% |
| 1-Year ReturnPast 12 months | +5.5% | +39.9% |
| 3-Year ReturnCumulative with dividends | +16.6% | +84.1% |
| 5-Year ReturnCumulative with dividends | +3.6% | +69.0% |
| 10-Year ReturnCumulative with dividends | +134.6% | +215.5% |
| CAGR (3Y)Annualised 3-year return | +5.2% | +22.6% |
Risk & Volatility
Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.
Risk & Volatility
HON is the less volatile stock with a 0.74 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.74x | 1.52x |
| 52-Week HighHighest price in past year | $248.18 | $165.15 |
| 52-Week LowLowest price in past year | $186.76 | $106.53 |
| % of 52W HighCurrent price vs 52-week peak | +87.4% | +89.6% |
| RSI (14)Momentum oscillator 0–100 | 32.3 | 48.4 |
| Avg Volume (50D)Average daily shares traded | 3.7M | 2.8M |
Analyst Outlook
Evenly matched — HON and EMR each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates HON as "Buy" and EMR as "Buy". Consensus price targets imply 12.5% upside for HON (target: $244) vs 9.5% for EMR (target: $162). For income investors, HON offers the higher dividend yield at 2.14% vs EMR's 1.42%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $243.83 | $161.92 |
| # AnalystsCovering analysts | 28 | 41 |
| Dividend YieldAnnual dividend ÷ price | +2.1% | +1.4% |
| Dividend StreakConsecutive years of raises | 15 | 37 |
| Dividend / ShareAnnual DPS | $4.63 | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.8% | +1.5% |
EMR leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). HON leads in 1 (Valuation Metrics). 2 tied.
HON vs EMR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is HON or EMR a better buy right now?
For growth investors, Honeywell International Inc.
(HON) is the stronger pick with 7. 8% revenue growth year-over-year, versus 3. 0% for Emerson Electric Co. (EMR). Honeywell International Inc. (HON) offers the better valuation at 29. 5x trailing P/E (20. 6x forward), making it the more compelling value choice. Analysts rate Honeywell International Inc. (HON) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HON or EMR?
On trailing P/E, Honeywell International Inc.
(HON) is the cheapest at 29. 5x versus Emerson Electric Co. at 36. 6x. On forward P/E, Honeywell International Inc. is actually cheaper at 20. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Emerson Electric Co. wins at 5. 04x versus Honeywell International Inc. 's 11. 22x.
03Which is the better long-term investment — HON or EMR?
Over the past 5 years, Emerson Electric Co.
(EMR) delivered a total return of +69. 0%, compared to +3. 6% for Honeywell International Inc. (HON). Over 10 years, the gap is even starker: EMR returned +215. 5% versus HON's +134. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HON or EMR?
By beta (market sensitivity over 5 years), Honeywell International Inc.
(HON) is the lower-risk stock at 0. 74β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 105% more volatile than HON relative to the S&P 500. On balance sheet safety, Emerson Electric Co. (EMR) carries a lower debt/equity ratio of 68% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — HON or EMR?
By revenue growth (latest reported year), Honeywell International Inc.
(HON) is pulling ahead at 7. 8% versus 3. 0% for Emerson Electric Co. (EMR). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -15. 5% for Honeywell International Inc.. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HON or EMR?
Emerson Electric Co.
(EMR) is the more profitable company, earning 12. 7% net margin versus 12. 6% for Honeywell International Inc. — meaning it keeps 12. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus 17. 5% for HON. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HON or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Emerson Electric Co. (EMR) is the more undervalued stock at a PEG of 5. 04x versus Honeywell International Inc. 's 11. 22x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Honeywell International Inc. (HON) trades at 20. 6x forward P/E versus 22. 8x for Emerson Electric Co. — 2. 2x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for HON: 12. 5% to $243. 83.
08Which pays a better dividend — HON or EMR?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 1. 4% for Emerson Electric Co. (EMR).
09Is HON or EMR better for a retirement portfolio?
For long-horizon retirement investors, Honeywell International Inc.
(HON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 74), 2. 1% yield, +134. 6% 10Y return). Emerson Electric Co. (EMR) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HON: +134. 6%, EMR: +215. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HON and EMR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.